Soleno earnings release
WebSoleno Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View SLNO financial statements in full. WebSoleno Therapeutics, Inc. (SLNO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Soleno earnings release
Did you know?
WebNov 9, 2024 · Soleno Therapeutics (SLNO) reported a 3rd Quarter September 2024 loss of $0.76 per share on revenue of $0.0 million. ... Earnings Release. Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results. REDWOOD CITY, Calif., Nov. 09, ... WebAug 10, 2024 · Soleno intends to meet with regulatory authorities later this year to determine next steps Closed public offering of common stock in June 2024, with net proceeds of approximately $53.7 million ...
Web2 days ago · SLNO: Soleno Therapeutics Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. ... This is an estimated date of earnings … WebApr 2, 2024 · Soleno Therapeutics (SLNO) will release its next earnings report on Apr 3, 2024. In the last quarter Soleno Therapeutics reported -$0.91 EPS in relation to -$0.76 …
WebSoleno Therapeutics Inc has confirmed Earnings date and time. It is on Wed 10 Aug (In 5 Days). The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) … WebSoleno Therapeutics, Inc. (SLNO) latest earnings report: revenue, EPS, surprise, history, news and analysis.
WebMar 21, 2024 · About DCCR (Diazoxide Choline) Extended-Release TabletsDCCR is a novel, proprietary extended-release dosage form containing the crystalline salt of diazoxide and …
WebDec 19, 2024 · Earnings Calendar; Market Screener; ... Extended-Release Tablets DCCR is a ... About Soleno Therapeutics, Inc. Soleno is focused on the development and … on the torsion of conical shellsWebApr 10, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Soleno Therapeutics stock is Buy based on the current 1 buy rating for SLNO. … iosco county primary election resultsWebFind the latest Earnings Report Date for Soleno Therapeutics, Inc. Common Stock (SLNO) ... Latest Press Release Published. Published. Earnings Per Share Estimated Reported. iosco county mi waterfront homes for saleWebJan 26, 2024 · Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), is currently being evaluated in a Phase 3 clinical development program. on the town 1949 castWebDec 19, 2024 · 19 December 2024, 8:00 am · 5-min read. Soleno Therapeutics. Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala … iosco county mi election resultsWebApr 13, 2024 · Electrameccanica Vehicles has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 11th, 2024 based off … on the touchpadWebJun 9, 2024 · Shares in Soleno Therapeutics, Inc. are plunging over 45% in Tuesday’s pre-market trading after the company announced disappointing top-line results from its Phase III trial evaluating once-daily Diazoxide Choline Controlled Release (DCCR) tablets for patients with Prader-Willi Syndrome (PWS).The Destiny PWS study did not meet its primary … iosco county ordinances